Immunotherapy associated Sweet syndrome in a patient with metastatic melanoma: A case report

• Egile Nagusiak: Rory Barry (Egilea), Gregg Murray (Egilea), Sally McGrath (Egilea), Clive Kilgallen (Egilea), Karen Eustace (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2024-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Immunotherapy agents are now widely used in the treatment of metastatic melanoma. Immune‐related adverse events (irAEs) may occur, including cutaneous pathologies in 50% of patients. We report a case of Sweet syndrome (SS) in a patient who was prescribed ipilimumab and nivolumab for metasta...